Filter
706
Filtered Results: 706
Text search:
virus
variants
Featured
Recommendations
88
New Publications
76
Language
Document type
No document type
185
Guidelines
184
Studies & Reports
146
Fact sheets
64
Strategic & Response Plan
47
Manuals
34
Situation Updates
13
Training Material
9
Videos
8
Resource Platforms
7
Brochures
5
Infographics
3
Online Courses
1
Countries / Regions
Brazil
30
Global
28
Germany
26
Latin America and the Carribbean
23
India
22
Africa
15
Western and Central Europe
15
Senegal
14
Congo, Democratic Republic of
14
Kenya
11
Malawi
9
Rwanda
8
West and Central Africa
8
South Africa
8
Nigeria
7
Burkina Faso
7
Peru
7
Mozambique
7
East and Southern Africa
7
Central African Republic
7
Colombia
6
Benin
6
Cameroon
6
Argentina
6
South Sudan
6
Togo
5
Niger
5
Venezuela
5
Middle East and North Africa
5
Eastern Europe
5
Syria
4
Philippines
4
Guinea
4
Haiti
4
Paraguay
4
Spain
4
Bolivia
4
Russia
4
Ethiopia
4
Ecuador
4
Madagascar
4
Chile
3
Zimbabwe
3
Morocco
3
South–East Asia Region
3
Uganda
3
Iraq
3
Liberia
3
Ukraine
2
Turkey
2
Ghana
2
Sierra Leone
2
Cambodia
2
Asia
2
Eastern Europe and Central Asia
2
France
2
Tunisia
2
Portugal
2
Côte d’Ivoire / Ivory Coast
2
Lebanon
2
Bangladesh
2
Sudan
2
Mali
2
Angola
2
Chad
2
Tajikistan
1
Mexico
1
El Salvador
1
Kazakhstan
1
Estonia
1
Congo-Brazzaville
1
Afghanistan
1
Qatar
1
Mauritania
1
Italy
1
Dominican Republic
1
Guinea-Bissau
1
Jordan
1
Saudi Arabia
1
Western Pacific Region
1
Gabon
1
United Kingdom
1
Belarus
1
Israel
1
Southern Africa
1
Vietnam
1
Nicaragua
1
Moldova
1
Namibia
1
Egypt
1
Yemen
1
Honduras
1
Libya
1
Zambia
1
Somalia
1
Eswatini/ Swaziland
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
263
Clinical Guidelines
52
Public Health
25
Key Resources
24
Pharmacy & Technologies
18
Women & Child Health
17
Capacity Building
4
Annual Report MEDBOX
1
Toolboxes
COVID-19
311
Rapid Response
39
HIV
39
Planetary Health
21
TB
20
Ebola & Marburg
19
NTDs
17
Mental Health
15
Refugee
15
AMR
12
Global Health Education
11
Health Financing Toolbox
10
Caregiver
8
NCDs
6
Pharmacy
5
Conflict
3
Zika
3
Polio
3
Specific Hazards
2
Natural Hazards
2
Cholera
2
Malaria
1
22 April 2022, This document provides updated interim recommendations on the use of masks by health workers providing care to patients with suspected or confirmed COVID-19. This update is prompted by new evidence around mask use and COVID-19 transmission, as well as the emergence of variants of conc...
Les pays du monde entier sont confrontés à des situations épidémiologiques diverses, et disposent de capacités de réaction différentes et d’un accès inégal aux outils permettant de sauver des vies. L’Organisation mondiale de la Santé (OMS) recommande aux autorités nationales de contin...
Cervical cancer is the fourth most common cancer in women worldwide in 2018, with 570,000 new cases and 311,000 deaths occurring annually.T he highest incidence rates are in Southern Africa, Eastern Africa, SubSaharan Africa, Western Africa, Melanesia, and Middle Africa . It also ranks as the leadin...
mBio, Vol. 6 Issue 2, March/April 2015
Available evidence demonstrates that direct patient contact and contact with infectious body fluids are the primary modes for Ebola virus transmission, but this is based on a limited number of studies. In this review, the authors address what we know and what ...
O Plano Nacional de Preparação e Resposta para a doença por novo coronavírus (COVID-19) é uma ferramenta estratégica de preparação e resposta a uma potencial epidemia pelo vírus SARS-CoV-2. Este Plano tem como referencial as orientações da Organização Mundial da Saúde e do Centro Europ...
The key to a lasting world free of all forms of poliovirus lies in rapidly interrupting all remaining endemic transmission of WPV in the endemic areas of Pakistan and Afghanistan. This is the only way to ensure that such strains do not re-emerge globally through international spread. It lays the cor...
COVID-19 Progress Report PAHO/WHO Argentina: 24 February 2022
Epidemiología; Resumen de puntos clave de conferencias y declaraciones de interés de OPS/OMS; Variantes de interés y preocupación; Actualización en vacunas; OPS/OMS en redes sociales; Publicaciones relacionadas; Noticias de la Regi...
10 May 2021. Manufactureres:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
The ChAdOx1-S/nCoV-19 [recombinant] vaccine is a replication-deficient adenoviral vecto...
A erradicação da varíola humana (mpox em inglês) foi certificada em 1980. A varíola símia (mpox em inglês) é endêmica nos países da África Central e Ocidental desde a sua primeira detecção, em 1958. Trata-se de uma zoonose cujos casos geralmente ocorrem perto de florestas tropicais, ond...
While much progress has been achieved over the past year, the Region of the Americas has stubbornly remained the epicenter of the COVID-19 pandemic. PAHO is launching its 2021 COVID-19 Response Strategy and Donor Appeal to continue supporting Latin American and Caribbean countries and territories i...
The growing understanding of how sequence information can contribute to improved public health is driving global investments in sequencing facilities and programmes. The falling cost and complexity of generating GSD provides opportunities for expanding sequencing capacity; however, challenges to wid...
The growing understanding of how sequence information can contribute to improved public health is driving global investments in sequencing facilities and programmes. The falling cost and complexity of generating GSD provides opportunities for expanding sequencing capacity; however, challenges to wid...
La dosis de refuerzo está indicada una vez transcurridos los 4 meses (120 días) de la última dosis del esquema inicial y será con vacuna de plataforma ARNm: Pfizer-BioNTech pediátrica a partir de los 5 años o Moderna para uso pediátrico a partir de los 6 años.
This technical guidance aims to provide guidelines to laboratories and relevant stakeholders in the European Union (EU), European Economic Area (EEA) and other countries in the WHO European region in making decisions on establishing sequencing capacities and capabilities, in making decisions on whic...
doi: https://doi.org/10.1101/2020.10.28.20221143
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
ECDC Technical Report
In line with ECDC’s recommendations provided in the ’Risk Assessment of HTLV-1/2 transmission by tissue/cell transplantation’ dated 14 March 2012, this Directive replaces the term ‘incidence’ with ‘prevalence’ in the description of endemic areas of HTLV-1/2 i...
In line with ECDC’s recommendations provided in the ’Risk Assessment of HTLV-1/2 transmission by tissue/cell transplantation’ dated 14 March 2012, this Directive replaces the term ‘incidence’ with ‘prevalence’ in the description of endemic areas of HTLV-1/2 i...
Die folgenden Empfehlungen sind als Unterstützung und Anregung gedacht, die stets individüll angepasst und abgewandelt werden können. Sie basieren auf unserem Wissensstand vom23.03.2020-
Rediscovering Biology
Molecular to Global Perspectives
Accessed: 03.09.2019
A new version is published in 2014
